Kaliumklorid Orifarm

Potassium Chloride, the active ingredient in Kaliumklorid Orifarm, is an electrolyte supplement presented as an oral formulation for oral administration. Marketed in the European Union, it supplies potassium ions to restore normal serum potassium concentrations and correct hypokalemia, a condition of potassium deficiency, in patients who require potassium replacement therapy.

GNH USA supplies Kaliumklorid Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, transplant centres and oncology centres worldwide, ensuring quality and regulatory compliance across global markets continually.

Kaliumklorid Orifarm, an oral potassium chloride electrolyte supplement, is used to manage conditions associated with low serum potassium.

- Hypokalemia: restores normal serum potassium levels in patients with clinically significant potassium depletion. - Potassium deficiency: provides potassium ions to correct dietary or disease‑related deficits. - Diuretic‑induced potassium loss: helps maintain potassium balance in patients receiving potassium‑wasting diuretics.

Oral potassium chloride may be associated with several adverse reactions, which are categorized by frequency and clinical significance.

Common Side Effects: - Nausea: mild stomach upset that may occur after ingestion. - Vomiting: occasional expulsion of stomach contents. - Abdominal discomfort: cramping or pain in the stomach region. - Diarrhea: loose stools occurring after dosing. - Constipation: reduced bowel movements in some patients. - Taste disturbance: metallic or salty taste perception.

Serious or Rare Side Effects: - Hyperkalemia: dangerously high serum potassium that can affect heart rhythm. - Cardiac arrhythmia: irregular heartbeat potentially leading to serious outcomes. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Gastrointestinal ulceration: rare erosion of the stomach lining.

When prescribing Kaliumklorid Orifarm, clinicians should consider several precautionary measures to ensure safe use.

- Assess serum potassium: verify low potassium levels before initiating therapy. - Monitor renal function: impaired kidneys may reduce potassium excretion. - Review concomitant medications: avoid use with potassium‑sparing diuretics or ACE inhibitors without monitoring. - Adjust dose in elderly: older patients may be more sensitive to electrolyte shifts. - Avoid in hyperkalemia: do not administer if serum potassium is already elevated. - Store at ambient temperature: keep below 25°C in the original container, protected from moisture.

Potassium chloride can interact with various medicines, influencing potassium balance or drug absorption.

Major Interactions (Avoid): - ACE inhibitors or ARBs: may cause additive hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): increase risk of dangerous potassium elevation. - NSAIDs: can reduce renal potassium excretion, raising serum levels.

Moderate Interactions (Monitor Closely): - Digoxin: high potassium can diminish digoxin toxicity but low levels increase risk. - Trimethoprim‑sulfamethoxazole: may impair potassium handling and cause hyperkalemia. - Lithium: altered renal clearance may affect lithium levels.